Agilon Health (AGL) Debt to Equity (2020 - 2025)
Agilon Health's Debt to Equity history spans 6 years, with the latest figure at $0.28 for Q4 2025.
- For Q4 2025, Debt to Equity rose 273.03% year-over-year to $0.28; the TTM value through Dec 2025 reached $0.28, up 273.03%, while the annual FY2025 figure was $0.28, 273.03% up from the prior year.
- Debt to Equity reached $0.28 in Q4 2025 per AGL's latest filing, up from $0.11 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.28 in Q4 2025 to a low of -$0.33 in Q1 2021.
- Average Debt to Equity over 5 years is $0.05, with a median of $0.05 recorded in 2023.
- Peak YoY movement for Debt to Equity: decreased 7.98% in 2023, then soared 273.03% in 2025.
- A 5-year view of Debt to Equity shows it stood at $0.04 in 2021, then decreased by 5.76% to $0.04 in 2022, then surged by 39.6% to $0.06 in 2023, then increased by 27.06% to $0.07 in 2024, then skyrocketed by 273.03% to $0.28 in 2025.
- Per Business Quant, the three most recent readings for AGL's Debt to Equity are $0.28 (Q4 2025), $0.11 (Q3 2025), and $0.09 (Q2 2025).